InMed Pharmaceuticals
11 hedge funds and large institutions have $65K invested in InMed Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
81% less capital invested
Capital invested by funds: $342K → $65K (-$277K)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$58K | |
| 2 | -$50.3K | |
| 3 | -$37K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$17K |
| 5 |
Millennium Management
New York
|
-$13K |